Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
VSee HealthVSEE -27.27% Net Cash per Share is $-0.16 as of Jun. 2026. The stock has 5 warning signs investors should review. Among 143 Healthcare Providers & Services companies, VSee Health ranks worse than 699300% on this metric.
The historical rank and industry rank for VSee Health's Net Cash per Share or its related term are showing as below:
VSEE's Price-to-Net-Cash is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 8.32 * Ranked among companies with meaningful Price-to-Net-Cash only.
VSee Health (OTCPK:VSEE) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
VSee Health Net Cash per Share Related Terms
VSee Health Net Cash per Share Historical Data
* Premium members only.
The historical data trend for VSee Health's Net Cash per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VSEE vs HCTI, MNDR, ACON: Net Cash per Share Comparison
For the Health Information Services subindustry, VSee Health's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
VSee Health Price-to-Net-Cash vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, VSee Health's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where VSee Health's Price-to-Net-Cash falls into.
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
VSee Health's Net Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VSee Health (VSEE) has a Net Cash per Share of $-0.16 as of Jun. 2026. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on VSee Health and its competitors. According to the industry distribution chart, VSee Health ranks #999999 out of 143 companies in the Healthcare Providers & Services industry.
Is VSee Health's Net Cash per Share too high?
VSee Health's current Net Cash per Share is $-0.16. Based on the distribution chart, VSee Health ranks #999999 out of 143 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does VSee Health's Net Cash per Share compare to HCTI and MNDR?
According to the Healthcare Providers & Services industry distribution chart, VSee Health ranks #999999 out of 143 companies for Net Cash per Share. This places VSee Health in the lower half of its industry. The industry median Net Cash per Share is 8.32. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Cash per Share for a Healthcare Providers & Services company?
The median Net Cash per Share among Healthcare Providers & Services companies is 8.32, based on 143 companies in the industry. Companies in the top quartile (top 25%) have a Net Cash per Share significantly above this median, while those in the bottom quartile fall well below. However, Net Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Cash per Share mean?
A high Net Cash per Share can signal that a stock is expensive relative to its fundamentals. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on VSee Health and its competitors. For the Healthcare Providers & Services industry, the median Net Cash per Share is 8.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. VSee Health's current Net Cash per Share is $-0.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VSee Health stock overvalued right now?
VSee Health (VSEE) has a current Net Cash per Share of $-0.16. The current Net Cash per Share is $-0.16. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Cash per Share calculated?
Net Cash per Share is calculated from a company's financial statements. For VSee Health (VSEE), the current Net Cash per Share is $-0.16 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
VSee Health Inc is a telehealth software platform offer a comprehensive telehealth platform for U.S. hospitals and enterprises. Through VSee Lab, the company offer a set of telehealth software building blocks, data connectors, and workflow templates that can be rapidly configured into the clients workflows. Companies offerings allow clinicians without programming experience to configure building blocks into their existing workflow without requiring programmers. These set of building blocks can connect to electronic medical record systems such as EPIC and Cerner via HL7, FHIR, and sFTP. The entire telehealth platform sits on a scalable server architecture and is HIPAA compliant and SOC2 externally audited.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VSEE has been successfully added to your 
